ID
18286
Beschrijving
A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.; ODM derived from: https://clinicaltrials.gov/show/NCT00240032
Link
https://clinicaltrials.gov/show/NCT00240032
Trefwoorden
Versies (1)
- 27-10-16 27-10-16 -
Geüploaded op
27 oktober 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Multiple Sclerosis NCT00240032
Eligibility Multiple Sclerosis NCT00240032
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Immunomodulation | Copaxone
Datatype
boolean
Alias
- UMLS CUI [1]
- C1963758
- UMLS CUI [2]
- C0528175
Beschrijving
Injection Self Subcutaneous Unable
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1828121
- UMLS CUI [1,2]
- C0036588
- UMLS CUI [1,3]
- C1522438
- UMLS CUI [1,4]
- C1299582
Beschrijving
Pregnancy | Pregnancy, Planned | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0032992
- UMLS CUI [3]
- C0006147
Beschrijving
Study Subject Participation Status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Multiple Sclerosis NCT00240032
- StudyEvent: Eligibility
C1828121 (UMLS CUI [1,2])
C0036588 (UMLS CUI [1,3])
C0528175 (UMLS CUI [2])
C0036588 (UMLS CUI [1,2])
C1522438 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])